BioMarin Pharma (BMRN) says not presenting at ASH 2016 - Bloomberg
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
BioMarin Pharma (NASDAQ: BMRN) says not presenting at ASH 2016 - Bloomberg, citing emailed message
The company is planning to offer an update on BMN 270 at a biotech meeting in January 2017.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gabelli Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
- Options with increasing put volume on December 8
- Stocks with Implied Volatility Movement
Create E-mail Alert Related CategoriesFDA, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!